Page 82 - AI for Good-Innovate for Impact
P. 82
AI for Good-Innovate for Impact
challenges, a groundbreaking approach integrating nanosecond pulse technology with artificial
intelligence (AI) has emerged. This innovative fusion aims to revolutionize tumor ablation
procedures, optimize treatment outcomes, and reduce postoperative complications.
Solution Overview: The solution combines nanosecond pulse technology, which delivers
precise electrical pulses to destroy tumor cells, with advanced AI algorithms. This integration
enhances preoperative image planning and intraoperative navigation, allowing for targeted
tumor management and real-time monitoring. By leveraging AI's capabilities, surgeons can
optimize treatment planning and execution, improving accuracy and effectiveness in tumor
ablation procedures.
Partners: Zhejiang University collaborates with R-ablation to advance this pioneering approach
to tumor ablation. Through this partnership, expertise from academic and industry sectors
contributes to developing and implementing this innovative solution.
UN Goals: Fusing nanosecond pulse technology with AI directly contributes to SDG 3: Good
Health and Well-being. By enhancing tumor ablation procedures, this solution reduces mortality
rates, decreases treatment costs, and minimizes disease burden. Furthermore, improving
treatment accessibility and reducing disparities aligns with the broader agenda of promoting
health equity and well-being for all.
16�2�2� Future work
Future work will focus on further optimizing preoperative image planning and intraoperative
navigation through advanced AI techniques. Expanding clinical trials and reducing technology
costs will enhance the solution's accessibility and effectiveness. These efforts aim to accelerate
progress towards achieving the Sustainable Development Goals, particularly Goal 3, by
ensuring equitable access to high-quality healthcare services.
16�3� Use case requirements
• REQ-01: Precision Tumor Ablation
• REQ-02: Optimized Treatment Planning
• REQ-03: Real-time Monitoring and Analysis
16�4� Sequence diagram
66
